Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism. - Wikidata - thesis-toulmin - TriplyDB

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

http://www.wikidata.org/entity/Q34225321

about

Pharmacogenetics of follicle-stimulating hormone action Congenital hypogonadotropic hypogonadism due to GnRH receptor mutations in three brothers reveal sites affecting conformation and coupling Spreading the clinical window for diagnosing fetal-onset hypogonadism in boys Gender dysphoria associated with disorders of sex development.Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.Psychosexual development in men with congenital hypogonadotropic hypogonadism on long-term treatment: a mixed methods study.Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations.Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients.Mini puberty and its interpretation Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients Hypothalamic control of the male neonatal testosterone surge.Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach.GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.Control of puberty onset and fertility by gonadotropin-releasing hormone neurons.Prevalence of KISS1 Receptor mutations in a series of 603 patients with normosmic congenital hypogonadotrophic hypogonadism and characterization of novel mutations: a single-centre study.Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life Differences between lutropin-mediated and choriogonadotropin-mediated receptor activation.Genetic testing facilitates prepubertal diagnosis of congenital hypogonadotropic hypogonadism.Male Central Hypogonadism in Paediatrics - the Relevance of Follicle-stimulating Hormone and Sertoli Cell Markers

P2860

Q27009516-3CE97812-E839-4DA6-8EC5-DCB0917A1541 Q28484094-14BE03AA-DB15-4BB7-A1EF-2626B27B1DB1 Q33605955-93403FAA-2193-4732-A600-EAA0D1376CA6 Q34304514-D617ED72-73AF-4990-8ABB-DCCA6A8A403D Q34486033-072A0709-C627-414F-A13C-A77D3AA18137 Q35236695-C39C42E3-CD92-4E5D-A0E7-C166A4AB3267 Q35602910-5E632320-D75A-42EC-B069-BFAEAE0C0645 Q35604421-4254F0AE-F07A-46C9-BF85-9B679D466C00 Q35712677-D9727B24-9678-437E-A944-63ED9F45C5B4 Q36663898-465A64BF-1BE1-4127-9658-4F47B80A96AB Q36672387-53C92810-752E-4545-BE2C-6F7FB97382BB Q38069128-5F03C482-AEDF-4095-B847-E7CB1A95682D Q38682630-F29802F8-8FEC-4102-8263-E90A4CEA3A5E Q38839109-DC7A8385-FE7F-4094-84BF-84C264FF70E8 Q39838836-A6214EEC-FC04-4BAC-8866-222AF63A6747 Q42429747-F66EF667-E760-410A-8080-6319354EA3A7 Q46725788-BE7EA52A-FE58-41D7-9569-18F81C918F27 Q48240276-35120205-5022-43C8-ADBA-C634258786DB Q57822724-6277D553-578C-4930-BF65-FC7D33A9E648

P2860

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

http://www.wikidata.org/entity/Q34225321

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

@ast

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

@en

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

@nl

type

label

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

@ast

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

@en

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

@nl

prefLabel

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

@ast

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

@en

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

@nl

P1433

Q34225321-1D8A36E0-1617-45D1-870E-263A004664F7

P1476

Q34225321-236E6C84-8378-429B-849F-5969141E40CD

P2093

Q34225321-19A6F82C-D37C-4202-BD56-9D6A78D8C4EF

Q34225321-60F6E7A6-ED32-4738-B37C-529B846D7C7A

Q34225321-EEA00B60-E38C-43A1-A54A-09CDDF4A4893

Q34225321-EEBC124B-E96C-4BA9-9F01-3BA0D9AE6D7A

P2860

Q34225321-03C59CFE-FA3B-40AC-82D4-B72ED7C41938

Q34225321-07ED8590-79F6-4831-8B8D-7B7B95147687

Q34225321-09F02ADF-2B74-4907-840A-1D9D8227A735

Q34225321-0F2F9DBF-0A02-4571-8CCA-54D38E5BEE98

Q34225321-143430F7-56D5-4024-974A-30468FD7D75B

Q34225321-1562EE25-40E4-4D48-80E5-96295C31FD25

Q34225321-199E38C5-7127-4AF5-B063-FD271584EDE5

Q34225321-1D2B00AE-B09E-441C-853B-828E6093D725

Q34225321-2015E34A-6DBF-4811-8EA8-3F91AEAE2C84

Q34225321-20A59946-ECDB-496C-AD92-DC1EB46627D1

P2888

Q34225321-780439DB-81F4-4C1D-83DA-BFE82CE93049

P304

Q34225321-3122E072-DD44-47FA-83D3-774F3915FA79

P31

Q34225321-9BAE194D-F6BE-4732-80D6-89357DDAD090

P356

Q34225321-B84855D5-C6FC-468F-AEFA-DA0715CF42B9

P433

Q34225321-8A220192-D6B3-4E17-BA81-B6EE4F30EFB7

P478

Q34225321-CDB060EA-5A4D-4AB6-8108-81F126D5CD68

P50

Q34225321-009610A4-144A-40F8-9302-4A2D56AABCF0

Q34225321-2CD61453-0CBD-4879-A368-F0A2E28E6228

P577

Q34225321-AD1A08E7-0FE6-461E-B542-C2427CE52579

P698

Q34225321-2414A5F7-A711-4056-A6AD-FCA79FE1C952

P921

Q34225321-BE70CFA8-CAB3-477C-AF65-51D045B1441D

P356

NRENDO.2011.164

P1433

Nature Reviews Endocrinology

P1476

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism

@en

P2093

Anne Guiochon-Mantel

http://www.w3.org/2001/XMLSchema#string

Catherine Dodé

http://www.w3.org/2001/XMLSchema#string

Claire Bouvattier

http://www.w3.org/2001/XMLSchema#string

Jérôme Bouligand

http://www.w3.org/2001/XMLSchema#string

P2860

Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester

WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome

Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice

Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility

Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinism

CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome

Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome

Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism

Impaired sexual activity in male adults with partial androgen insensitivity

Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus

P2888

nrendo.2011.164

P304

172-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRENDO.2011.164

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22009162

http://www.w3.org/2001/XMLSchema#string

P921